A B7H3-targeting antibody-drug conjugate in advanced solid tumors: a phase 1/1b trial. Ma Y, Yang Y, Huang Y, Fang W, et al. Nat Med 2025;31:1949-1957.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ma Y, Yang Y, Huang Y, Fang W, et al. A B7H3-targeting antibody-drug conjugate in advanced solid tumors: a phase 1/1b trial. Nat Med 2025;31:1949-1957.
PMID: 40082695